Mathison Immuno Scientific Incorporated Company Profile

01:31 EST 21st November 2017 | BioPortfolio

CUSTOM MONOCLONAL ANTIBODY SERVICE Difficult epitopes are our specialty. Antibody available in culture supernatant or ascites. Antibody purified to your specific requirements Competitive prices & Stepwise payment plan Confidentiality guarantee

News Articles [556 Associated News Articles listed on BioPortfolio]

Medigene announces formation of new Scientific Advisory Board

Medigene AG announced the appointment of eight leading experts to its new immuno-oncology-focused Scientific Advisory Board (SAB). The SAB will consult the company with regard to strategic options and...

Vical Incorporated Announces Pricing of $25 Million Underwritten Public Offering of Common Stock

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock ...

Is immuno-oncology shaping the oncology product development landscape?

Steven Powell, chief executive of UK-based immuno-oncology (I-O) company Macrophage Pharma, gives an…

Cancer Research UK Teams Up with London Startup in Immuno-oncology

Biotecnol, based in London, has found a partner in CRUK to bring its immune-stimulating antibody into the clinic to tackle solid tumors. There will (probably) be a new immuno-oncology drug on the bloc...

Tesaro partners with Evotec on immuno-oncology study

Tesaro signed a three-year deal with Evotec that aims to develop small-molecule inhibitors against an undisclosed immuno-onco -More- 

Belgian Biotech Grows its Pipeline of Immuno-Oncology Therapies

Oncurious has licensed five immuno-oncology candidates developed at VIB to expand its pipeline of cancer therapies. The young Belgian biotech Oncurious has decided to step up its game through an agree...

PeptiDream collaborates with Kleo for immuno-oncology drug research

Tokyo-based PeptiDream agreed to work with Kleo Pharmaceuticals on the development of immuno-oncology drugs for multiple indi -More- 

BMS to use Halozyme’s Enhanze technology to develop immuno-oncology medicines

Bristol-Myers Squibb (BMS) has partnered with Halozyme Therapeutics for the development of immuno-oncology medicines.

PubMed Articles [490 Associated PubMed Articles listed on BioPortfolio]

Disseminated histoplasmosis in an immuno-competent young male: Role of bone marrow examination in rapid diagnosis.

Fungal infections are usually seen in elderly or immuno-compromised individuals particularly with human immunodeficiency virus infection. In immuno-competent individuals, they seldom present with over...

Immunomodulatory basis of antioxidant therapy and its future prospects: an appraisal.

Antioxidants are agents which can modulate oxidant-antioxidant profile of body system by neutralizing pro-oxidant molecules. The current scientific knowledge on mechanisms of antioxidant activity of b...

A Case for a Human Immuno-Peptidome Project Consortium.

A multidisciplinary group of researchers gathered at the Hönggerberg Campus at ETH Zurich, Switzerland, for the first meeting on the Human Immuno-Peptidome Project (

Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation.

New immuno-oncology (I-O) therapies that harness the immune system to fight cancer call for a re-examination of the traditional parametric techniques used to model survival from clinical trial data. M...

Checkpoint inhibitors: a cutting edge in oncology.

The checkpoint inhibitor field, and indeed the whole of immuno-oncology, is fast-paced and fascinating, with huge clinical and commercial potential. The challenge in the coming years will be to define...

Clinical Trials [1235 Associated Clinical Trials listed on BioPortfolio]

Exposure Chamber Trial With Cat Immunotherapy

The main purpose of this trial is to investigate if any of three different doses of cat hair immunotherapy is safe for treatment of cat allergic patients.

Compatibility and Immunogenicity of a Short Specific Immunotherapy (SIT) in Contrast to Classic Specific Immunotherapy

We wanted to examine the immunogenicity and safety of a shortened specific immunotherapy in contrast to the standard specific immunotherapy. Therefore, we challenged 12 patients for 14 we...

Intralymphatic Immunotherapy in Increasing Doses, After Subcutaneous Immunotherapy

The study evaluates the safety and effect of intralymphatic allergen specific immunotherapy in increasing doses. Patients that have already undergone subcutaneous immunotherapy will be tre...

Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma

The purpose of this study is to determine the safety of making and giving Epstein-Barr virus (EBV) immunotherapy products to subjects with nasopharyngeal carcinoma (NPC) associated with EB...

The Safety and Efficacy of Sublingual/Oral Immunotherapy for the Treatment of Milk Protein Allergy

The purpose of this study is to determine if small oral and sublingual doses of milk protein are safe and effective in decreasing sensitivity to cow's milk in allergic children.

Companies [1010 Associated Companies listed on BioPortfolio]

Mathison Immuno Scientific Incorporated

CUSTOM MONOCLONAL ANTIBODY SERVICE Difficult epitopes are our specialty. Antibody available in culture supernatant or ascites. Antibody purified to your specific requirements Competitive prices & Step...

Bionor Immuno AS

Bionor Immuno is a multidisciplinary drug discovery company located in Skien, Norway. The major focus of the company is to develop effective peptide based immunotherapies, against infectious diseases ...

Immuno Laboratories

Headquartered in Fort Lauderdale, Florida, Immuno Laboratories is widely recognized as one of the leading food and environmental allergy testing facilities in the world. Since 197...

Immunotech Laboratories, Inc.

Headquartered in Monrovia, CA, Immunotech Laboratories is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitati...


SDI is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, reta...

More Information about "Mathison Immuno Scientific Incorporated" on BioPortfolio

We have published hundreds of Mathison Immuno Scientific Incorporated news stories on BioPortfolio along with dozens of Mathison Immuno Scientific Incorporated Clinical Trials and PubMed Articles about Mathison Immuno Scientific Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mathison Immuno Scientific Incorporated Companies in our database. You can also find out about relevant Mathison Immuno Scientific Incorporated Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record